Hemolytic uremic syndrome after multivisceral transplantation treated with intravenous immunoglobulin.
Post transplant hemolytic uremic syndrome (HUS) secondary to immunosuppressive regimen is becoming more common with increasing numbers of organ transplantation. We describe a case of refractory HUS secondary to immunosuppression post multivisceral transplantation, successfully managed with plasmapheresis and intravenous immunoglobulin (IVIG).
Banerjee
Debasish
D
Division of Nephrology and Transplantation, University of Miami, Miami, Florida 33136, USA.
Kupin
Warren
W
Roth
David
D
D058186:Acute Kidney Injury / Q000209:etiology / Q000628:therapy; D000328:Adult; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000097:blood / Q000209:etiology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007421:Intestine, Small / Q000637:transplantation; D016031:Liver Transplantation / Q000009:adverse effects; D016377:Organ Transplantation / Q000009:adverse effects*; D016035:Pancreas Transplantation; D010976:Platelet Count; D013270:Stomach / Q000637:transplantation
D016756:Immunoglobulins, Intravenous